KAREN CRUEY: Open Payments
NPI 1437180478 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,076 in 11 payments from 4 companies in 2025. Trend: 2023 $1,147 · 2024 $1,397 · 2025 $1,076
Food & beverage: $1,076
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $667 |
| Alkermes, Inc. | 3 | $261 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| Tris Pharma Inc | 1 | $24 |
Products named: VRAYLAR, ARISTADA, FANAPT, LYBALVI, Dyanavel XR.
Industry payments across NV — which companies pay providers there.
